diallyl disulfide has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY | 1 |
| Calvert, J; Lancon, JA; Parent, AD; Perkins, E; Zhang, J | 1 |
2 other study(ies) available for diallyl disulfide and Brain Neoplasms
| Article | Year |
|---|---|
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells.
Topics: Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Glioblastoma; Humans; Nanoparticles; Thymine | 2023 |
Inhibition of H-ras as a treatment for experimental brain C6 glioma.
Topics: Allyl Compounds; Animals; Antineoplastic Agents; Brain Neoplasms; Brain Tissue Transplantation; Disease Models, Animal; Disulfides; Down-Regulation; Drug Administration Schedule; Gene Expression Regulation; Genes, ras; Glioma; Male; Rats; Rats, Sprague-Dawley; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2003 |